Jackson Creek Investment Advisors LLC Sells 1,836 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Jackson Creek Investment Advisors LLC trimmed its position in DocuSign, Inc. (NASDAQ:DOCU) by 17.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,520 shares of the company’s stock after selling 1,836 shares during the period. Jackson Creek Investment Advisors LLC’s holdings in DocuSign were worth $766,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in DOCU. Itau Unibanco Holding S.A. purchased a new position in shares of DocuSign in the third quarter worth approximately $28,000. Kestra Investment Management LLC purchased a new position in shares of DocuSign during the 4th quarter worth $30,000. Brooklyn Investment Group bought a new stake in shares of DocuSign during the 3rd quarter valued at $33,000. Modus Advisors LLC purchased a new stake in shares of DocuSign in the 4th quarter worth $36,000. Finally, First Horizon Advisors Inc. raised its holdings in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares during the period. 77.64% of the stock is currently owned by institutional investors.

Insider Activity at DocuSign

In other news, CFO Blake Jeffrey Grayson sold 15,588 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the sale, the chief financial officer now directly owns 85,851 shares in the company, valued at approximately $8,394,510.78. This represents a 15.37 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the completion of the transaction, the director now directly owns 906,430 shares of the company’s stock, valued at approximately $87,959,967.20. The trade was a 39.08 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 686,010 shares of company stock valued at $66,102,694. Insiders own 1.66% of the company’s stock.

DocuSign Stock Up 0.1 %

Shares of DocuSign stock opened at $79.83 on Friday. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The business has a 50-day moving average price of $89.05 and a 200-day moving average price of $78.45. The firm has a market cap of $16.13 billion, a price-to-earnings ratio of 16.46, a PEG ratio of 6.94 and a beta of 1.02.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Morgan Stanley boosted their price target on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Jefferies Financial Group boosted their price objective on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company raised their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, UBS Group raised their price objective on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.